Skip to main content

Table 4 Longitudinal association between comorbidities and oral anticoagulant use (OR 95% CI) during the entire follow-up. Data on comorbidities were defined time-dependently for the entire follow-up

From: Prevalence of oral anticoagulant use among people with and without Alzheimer’s disease

Comorbidity (Reference: no disease)

People with AD OR (95% CI)

People without AD OR (95% CI)

Atrial fibrillation

  < 6 months before

5.12 (4.90–5.36)

7.22 (6.87–7.57)

 6–12 months before

4.65 (4.42–4.88)

6.55 (6.22–6.90)

 More than one year before

4.34 (4.13–4.56)

5.79 (5.49–6.10)

Coronary artery bypass grafting

  < 6 months before

2.68 (2.40–3.00)

3.05 (2.79–3.35)

 6–12 months before

1.36 (1.21–1.53)

1.48 (1.34–1.63)

Percutaneous coronary intervention

  < 6 months before

13.58 (12.10–15.25)

17.99 (16.35–19.79)

 6–12 months before

4.51 (4.07–4.99)

5.54 (5.10–6.01)

Ischemic stroke

  < 6 months before

2.40 (2.30–2.51)

2.95 (2.81–3.10)

 6–12 months before

2.39 (2.29–2.51)

2.79 (2.65–2.93)

Pulmonary embolism

  < 6 months before

6.59 (5.93–7.33)

6.82 (6.13–7.58)

 6–12 months before

3.70 (3.35–4.10)

3.52 (3.18–3.89)

Deep venous thrombosis

  < 6 months before

7.54 (6.81–8.35)

5.86 (5.23–6.57)

 6–12 months before

2.81 (2.57–3.08)

2.35 (2.11–2.63)

Hemorrhagic stroke

  < 6 months before

1.20 (0.97–1.49)

1.45 (1.11–1.90)

 6–12 months before

0.95 (0.71–1.26)

1.14 (0.84–1.54)